SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-24-000047
Filing Date
2024-03-19
Accepted
2024-03-19 19:08:33
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710889691.html 4  
1 FORM 4 wk-form4_1710889691.xml 4 9902
  Complete submission text file 0001819790-24-000047.txt   11349
Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Mottiwala Aziz (Reporting) CIK: 0001788542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 24765696

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)